Latest Period
Q2 2026
Security Snapshot
EyePoint, Inc. - Common Stock, par value $0.001 (EYPT) Institutional Ownership
CUSIP: 30233G209
13F Institutional Holders and Ownership History from Q4 2020 to Q2 2026
Institutions Reporting
188
Shares (Excl. Options)
92,823,606
Price
$14.30
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001
- Symbol
- EYPT on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 92,823,606
- Total 13F value
- $1,327,184,211
- Portfolio coverage rank
- 0%
- Share change
- +3,412,562
- Value change
- +$50,276,962
- Number of holders
- 188
- Shares outstanding
- 83,832,335
- SEC-reported price per share
- $11.96
- Insider filing price
- $11.96
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- EYPT - EyePoint, Inc. - Common Stock, par value $0.001 is tracked under CUSIP 30233G209.
- 188 institutions reported positions in Q2 2026.
- 10 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 187 to 188 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,149,112,955 to $1,327,184,211.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 188 institutions filings for Q2 2026.
Security key
30233G209
Latest holder period
Q2 2026
13F holders
188
13D/G owners
10
CIK / CUSIP context first
Open Q2 2026 holders
EYPT full holder history
EyePoint, Inc. SEC filings
EyePoint, Inc. company facts
EyePoint, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 30233G209:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
10
Security
EYPT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 8.4% | -16% | $98,140,000 | -$17,735,300 | 7,000,000 | -15% | Cormorant Asset Management, LP | 30 Jun 2026 |
| BlackRock, Inc. | 7.7% | +17% | $91,955,821 | +$27,814,572 | 6,430,477 | +43% | BlackRock, Inc. | 30 Jun 2026 |
| Adage Capital Management, L.P. | 5.7% | +44% | $67,166,904 | +$20,900,904 | 4,790,792 | +45% | Adage Capital Management, L.P. | 30 Jun 2026 |
| FEDERATED HERMES, INC. | 6.7% | $43,281,744 | 4,599,450 | Federated Hermes, Inc. | 30 Jun 2025 | |||
| Commodore Capital LP | 5.1% | $57,077,500 | 4,250,000 | Commodore Capital LP | 27 May 2026 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5% | $59,212,278 | 4,223,415 | Vanguard Capital Management | 30 Jun 2026 | |||
| FRANKLIN RESOURCES INC | 6.1% | -18% | $27,059,688 | +$820,894 | 4,137,567 | +3.1% | Franklin Resources, Inc. | 31 Dec 2024 |
| TCG Crossover GP II, LLC | 4.3% | $62,265,799 | 3,572,335 | TCG Crossover GP II, LLC | 31 Dec 2025 | |||
| RA CAPITAL MANAGEMENT, L.P. | 4.7% | $20,809,090 | 3,181,818 | RA Capital Management, L.P. | 31 Dec 2024 | |||
| Paradigm Biocapital Advisors LP | 3.8% | -26% | $44,591,181 | -$14,897,003 | 3,142,437 | -25% | Paradigm BioCapital Advisors LP | 31 Mar 2026 |
As of 30 Jun 2026, 188 institutional investors reported holding 92,823,606 shares of EyePoint, Inc. - Common Stock, par value $0.001 (EYPT). This represents 111% of the company’s total 83,832,335 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
88%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 9.9% | 8,296,375 | 0% | 2.5% | $118,638,163 |
| BlackRock, Inc. | 8.9% | 7,463,197 | +4% | 0% | $106,723,718 |
| Cormorant Asset Management, LP | 8.4% | 7,000,000 | -15% | 5.1% | $100,100,000 |
| FEDERATED HERMES, INC. | 6.8% | 5,681,052 | +0.2% | 0.12% | $81,239,044 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.8% | 4,827,792 | +46% | 0.1% | $69,037,426 |
| FRANKLIN RESOURCES INC | 5.7% | 4,807,078 | -4.8% | 0.01% | $68,741,215 |
| Commodore Capital LP | 5.5% | 4,600,000 | +63% | 3.9% | $65,780,000 |
| Jupiter Topco LLC | 4.5% | 3,770,381 | 0% | 0.02% | $53,897,596 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 3,630,252 | +2% | 0% | $51,912,604 |
| Paradigm Biocapital Advisors LP | 3.4% | 2,890,397 | -8% | 0.77% | $41,332,677 |
| STATE STREET CORP | 2.8% | 2,357,545 | +12% | 0% | $33,712,894 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 2,062,390 | +4% | 0% | $29,497,382 |
| Aberdeen Group plc | 2.4% | 2,008,802 | +16% | 0.04% | $28,725,869 |
| CITADEL ADVISORS LLC | 2.4% | 1,977,610 | +3.8% | 0.02% | $28,279,823 |
| Balyasny Asset Management L.P. | 2.2% | 1,812,358 | +26% | 0.05% | $25,916,719 |
| Parkman Healthcare Partners LLC | 1.5% | 1,288,163 | -4.9% | 1.9% | $18,420,731 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.5% | 1,245,583 | 0% | 0.24% | $17,811,837 |
| TWO SIGMA INVESTMENTS, LP | 1.4% | 1,181,143 | +174% | 0.01% | $16,890,345 |
| Essex Woodlands Management, Inc. | 1.3% | 1,084,857 | 0% | 6.1% | $15,513,455 |
| ORBIMED ADVISORS LLC | 1.3% | 1,069,147 | 0% | 0.29% | $15,288,802 |
| 5AM Venture Management, LLC | 1.3% | 1,050,000 | 0% | 5.2% | $15,015,000 |
| Rosalind Advisors, Inc. | 1.2% | 988,230 | -4.7% | 5.3% | $14,131,689 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.2% | 971,014 | +22% | 0% | $13,885,500 |
| AMERIPRISE FINANCIAL INC | 1% | 848,410 | +100% | 0% | $12,132,298 |
| DIMENSIONAL FUND ADVISORS LP | 1% | 841,746 | +110% | 0% | $12,035,896 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
23
Latest
Q2 2026
Rows shown
1-23 of 23
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 92,823,606 | $1,327,184,211 | +$50,276,962 | $14.30 | 188 |
| 2026 Q1 | 89,144,622 | $1,149,112,955 | +$43,832,914 | $12.89 | 187 |
| 2025 Q4 | 83,462,381 | $1,524,933,420 | +$249,855,302 | $18.27 | 166 |
| 2025 Q3 | 69,898,687 | $995,227,037 | +$20,107,476 | $14.24 | 148 |
| 2025 Q2 | 68,912,118 | $648,484,078 | -$21,934,653 | $9.41 | 139 |
| 2025 Q1 | 74,070,140 | $401,203,753 | -$6,558,607 | $5.42 | 149 |
| 2024 Q4 | 74,299,852 | $553,357,101 | +$114,467,368 | $7.45 | 141 |
| 2024 Q3 | 58,498,731 | $476,138,776 | -$4,424,916 | $7.99 | 135 |
| 2024 Q2 | 58,415,381 | $508,206,601 | -$17,769,473 | $8.70 | 148 |
| 2024 Q1 | 55,009,467 | $1,137,046,639 | +$106,318,844 | $20.67 | 161 |
| 2023 Q4 | 49,565,894 | $1,145,491,759 | +$422,510,894 | $23.11 | 138 |
| 2023 Q3 | 33,709,262 | $269,337,991 | +$16,845,118 | $7.99 | 98 |
| 2023 Q2 | 31,573,084 | $274,685,383 | +$22,852,995 | $8.70 | 82 |
| 2023 Q1 | 29,111,970 | $85,592,348 | -$1,206,242 | $2.94 | 66 |
| 2022 Q4 | 29,377,926 | $102,818,972 | -$13,441,865 | $3.50 | 72 |
| 2022 Q3 | 30,106,241 | $238,140,639 | -$883,849 | $7.91 | 82 |
| 2022 Q2 | 30,200,779 | $237,683,742 | -$3,357,027 | $7.87 | 78 |
| 2022 Q1 | 30,440,222 | $369,919,357 | +$7,173,181 | $12.15 | 78 |
| 2021 Q4 | 29,839,293 | $365,363,130 | +$94,551,507 | $12.24 | 83 |
| 2021 Q3 | 22,128,108 | $230,547,815 | +$14,765,407 | $10.42 | 61 |
| 2021 Q2 | 20,739,059 | $186,447,743 | +$7,944,014 | $8.99 | 59 |
| 2021 Q1 | 19,642,118 | $199,571,620 | +$124,369,380 | $10.16 | 58 |
| 2020 Q4 | 7,703,318 | $50,684,935 | +$50,684,935 | $6.58 | 31 |